BREITENSTEIN, C., GREWE, T., FLÖEL, A., ZIEGLER, W., SPRINGER,
L., MARTUS, P., HUBER, W., WILLMES, K., RINGELSTEIN, E.
B., HAUSLER, K. G., ABEL, S., GLINDEMANN, R., DOMAHS,
F., REGENBRECHT, F., SCHLENCK, K.-J., THOMAS, M., OBRIG,
H., DE LANGEN, E., ROCKER, R., WIGBERS, F., RÜHMKORF,
C., HEMPEN, I., LIST, J., BAUMGAERTNER, A. and THE
FCET2EC STUDY GROUP, 2017, Intensive speech and
language therapy in patients with chronic aphasia after stroke:
a randomised, open-label, blinded-endpoint, controlled trial
in a health-care setting. Lancet, 389, 1528-1538.